Ivermectin & Fenbendazole Cancer Program | USA Integrative Clinic
A physician-guided, multi-modal program designed to support individuals exploring advanced, integrative cancer care.
Biologix Center offers a structured 10-week Cancer Synergy Program that incorporates emerging protocol-based strategies—such as ivermectin and fenbendazole—within a comprehensive, physician-directed care model.
Patients travel from across the United States and internationally to experience a more coordinated approach to complex health challenges.
A Structured 10-Week Cancer Protocol
Combining the Makis Cancer Protocol, targeted Induced Native Phage Therapy (INPT), and physician-guided integrative care.
This program is built around a coordinated protocol that includes:
- Metabolic support using compounds such as ivermectin, fenbendazole, and mebendazole under physician supervision
- Targeted Induced Native Phage Therapy (INPT) to address microbial and physiological contributors
- Daily physician-guided therapies during an intensive initial phase
- Ongoing weekly treatments and monitoring to adapt care in real time
Ivermectin & Fenbendazole in an Integrative Setting
Ivermectin and fenbendazole are part of a growing category of protocols being explored within integrative cancer care.
At Biologix Center, these compounds are:
- Reviewed and prescribed by a licensed physician when appropriate
- Integrated into a structured, multi-modal program
- Adjusted based on individual response and ongoing evaluation
This approach allows protocols to function within a coordinated system rather than as standalone solutions.
Built on a Proven Metabolic Protocol
This program incorporates a physician-guided protocol utilizing ivermectin, fenbendazole, and mebendazole—approaches that have been explored in thousands of cancer cases as part of emerging metabolic strategies.
At Biologix, this protocol is not used in isolation. It is integrated into a broader system designed to support the body while addressing multiple pathways simultaneously.
A Structured, Multi-Modal Approach to Complex Care
The Biologix Cancer Synergy Program is a comprehensive 10-week experience designed to bring together advanced integrative strategies, physician-guided care, and real-time treatment adaptation.
Rather than focusing on a single method, this program is built around a coordinated, full-system approach—supporting the body across multiple physiological pathways while continuously adjusting based on individual response.
This program is based on emerging protocols and clinical experience, combined with the foundational therapies Biologix Center has developed over years of treating complex conditions.
Where Advanced Protocols Meet Personalized Care
A Structured Approach to Integrative Cancer Care
Individuals researching ivermectin and fenbendazole protocols are often looking for more than a single therapy—they’re looking for a system.
At Biologix Center, these compounds are not used in isolation. They are evaluated and incorporated into a broader program designed to support the body across multiple systems. This is a program—not a single treatment.
THE 10-WEEK PROGRAM BREAKDOWN
WEEKS 1–3
INITIAL INTENSIVE PHASE
- Daily physician-guided treatments
- Integration of metabolic protocol (ivermectin, fenbendazole, mebendazole)
- INPT targeting microbial/physiological contributors
- Supportive therapies such as HBOT and therapeutic bodywork
- Real-time diagnostic testing and adjustments
WEEKS 4–10
ONGOING WEEKLY CARE
- 1x weekly EBOO therapy (10 total included in program)
- Weekly physician-guided treatment and evaluation
- Continued INPT and protocol support
- Strategic IV therapies (customized as needed)
- Nutritional support including ketogenic / low-inflammatory strategies and deuterium-depletion
AFTER 10 WEEKS
ONGOING TARGETED SUPPORT
- Continued care plan determined by the clinical team
- Follow-up support based on individual response
All therapies are administered based on individual evaluation and physician guidance.
Led by Experienced Clinical Oversight
Each patient begins with an initial
consultation conducted by Dr. Sujay Kumar, MD, who oversees all medical aspects of the program.
From prescriptions to ongoing care planning, the program is structured to ensure continuous clinical involvement and individualized decision-making throughout
the full 10-week experience.
Who This Program Is For?
This program may be appropriate for individuals who:
- Individuals exploring ivermectin or fenbendazole protocols
- Patients seeking integrative or alternative cancer support
- Those looking for a structured, physician-guided program
- Individuals willing to travel for intensive care
Program Structure & Investment
10-WEEK CANCER SYNERGY PROGRAM INVESTMENT: $45,000
Includes:
- Full 10-week structured care
program - Initial intensive phase (3 weeks)
- Weekly therapies and physician
follow-ups - Comprehensive treatment
planning and oversight
Frequently Asked Questions
Are You Ready To Start Your Journey?
Featured Articles
Hidden Infections, Mast Cells, and Overactive Immunity: How Phages Could Calm the Storm
Conceptual Mechanistic Framework for Induced Native Phage Therapy (INPT) in Multidrug-Resistant Infections and Tumor-Associated Microbiomes